GR3005282T3 - - Google Patents

Info

Publication number
GR3005282T3
GR3005282T3 GR920401612T GR920401612T GR3005282T3 GR 3005282 T3 GR3005282 T3 GR 3005282T3 GR 920401612 T GR920401612 T GR 920401612T GR 920401612 T GR920401612 T GR 920401612T GR 3005282 T3 GR3005282 T3 GR 3005282T3
Authority
GR
Greece
Prior art keywords
acid
alpha
ch3oo
na2seo4
mercaptoalanine
Prior art date
Application number
GR920401612T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005282T3 publication Critical patent/GR3005282T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920401612T 1989-05-11 1992-07-29 GR3005282T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0113089A AT394493B (de) 1989-05-11 1989-05-11 Pharmazeutisches praeparat zur behandlung von lebererkrankungen

Publications (1)

Publication Number Publication Date
GR3005282T3 true GR3005282T3 (el) 1993-05-24

Family

ID=3507244

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401612T GR3005282T3 (el) 1989-05-11 1992-07-29

Country Status (9)

Country Link
US (1) US5102910A (el)
EP (1) EP0397646B1 (el)
AT (2) AT394493B (el)
CA (1) CA2016470C (el)
CH (1) CH674311A5 (el)
DE (1) DE59000195D1 (el)
DK (1) DK0397646T3 (el)
ES (1) ES2043351T3 (el)
GR (1) GR3005282T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677179B2 (en) * 1992-02-19 1997-04-17 Bydder, Percy Vaughan Pharmaceutical compositions and their use for treating zinc deficient disorders
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
KR970008105B1 (ko) * 1993-06-28 1997-05-21 주식회사 미원 L-아스파테이트 또는 아스파라긴을 유효성분으로 함유하는 알콜성 장해 보호제 및 그의 제조방법
EP1574211A1 (en) * 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
WO2006061992A1 (ja) * 2004-12-10 2006-06-15 Ajinomoto Co., Inc. 肝疾患予防・治療用組成物
WO2009043106A1 (en) * 2007-10-03 2009-04-09 Velacor Therapeutics Pty Ltd Inorganic selenium and angiogenesis
US20090269796A1 (en) * 2007-12-05 2009-10-29 The General Hospital Corporation Methods of detecting and treating myocardial ischemia and myocardial infarction
DE102011001768A1 (de) 2011-04-04 2012-10-04 Gunnar Frank Präparat oder Nahrungsergänzungsmittel
KR102236226B1 (ko) 2013-05-08 2021-04-02 감브로 룬디아 아베 투석 제제
JP6913402B2 (ja) * 2017-11-30 2021-08-04 株式会社メディコ・コンスル 非アルコール性脂肪性肝炎(nash)の治療と予防に適した配合剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792034A1 (de) * 1964-09-28 1971-10-07 Yamanouchi Pharma Co Ltd Verwendung von Glutathion-Aminosaeure-Gemischen als Leberschutzmittel fuer Mensch und Tier
US4124718A (en) * 1977-01-21 1978-11-07 Merrell Toraude Et Compagnie Enhancing zinc serum and tissue levels
JPS6058908B2 (ja) * 1978-10-11 1985-12-23 参天製薬株式会社 システイン誘導体
US4758431A (en) * 1980-04-14 1988-07-19 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
IL61080A0 (en) * 1980-09-19 1980-11-30 Garfinkel D Pharmaceutical composition containing zinc ions
GB2090133A (en) * 1980-11-12 1982-07-07 Patterson Janice Anne Veterinary Composition containing Vitamin E and Selenium Compounds
JPS5832850A (ja) * 1981-08-22 1983-02-25 Santen Pharmaceut Co Ltd スルホシステイン誘導体
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
US4446154A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
JPS5916817A (ja) * 1982-07-16 1984-01-28 Eisai Co Ltd アミノ酸輸液
US4599234A (en) * 1983-10-07 1986-07-08 Amer M Samir Synergistic diet comprising selenium based compounds
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
JPS62258321A (ja) * 1986-05-01 1987-11-10 Senjiyu Seiyaku Kk 肝障害抑制剤
DE3628010A1 (de) * 1986-08-19 1988-02-25 Astra Chem Gmbh Arzneimittel fuer die verwendung bei der behandlung von hypertonie

Also Published As

Publication number Publication date
CA2016470C (en) 1995-11-07
CA2016470A1 (en) 1990-11-11
CH674311A5 (el) 1990-05-31
ATA113089A (de) 1991-10-15
EP0397646A1 (de) 1990-11-14
US5102910A (en) 1992-04-07
ATE77954T1 (de) 1992-07-15
EP0397646B1 (de) 1992-07-08
DE59000195D1 (de) 1992-08-13
ES2043351T3 (es) 1993-12-16
AT394493B (de) 1992-04-10
DK0397646T3 (da) 1992-08-24

Similar Documents

Publication Publication Date Title
CA2016659A1 (en) Stabilized compositions containing epidermal growth factor
AU575637B2 (en) Oral hygiene compositions
CA2151935A1 (en) Oral Compositions
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
DE2963928D1 (en) Composition for controlling dental plaque and calculus
HUT41951A (en) Process for producing insecticide compositions containing fluorinated ethers as active agents and process for producing the active agents
CA2015186A1 (en) Nutrient composition
GR3005282T3 (el)
EP0657176A3 (en) Composition with increased water solubility containing a compound insoluble or slightly soluble in water.
CA2180119A1 (en) The composition containing snapping turtle and tortoise, the preparation and the use thereof
AU5707090A (en) Hair treatment composition
DE3371030D1 (en) Insecticidal compositions having high concentration of active ingredients
NZ217778A (en) Antiinflammatory compositions containing piroxicam
AU562517B2 (en) Biostimulating agent containing creatine
DE3267766D1 (en) N-cyclohexyl-chloroacetamides, their preparation and their use in combating undesired plant growth
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
AU6482390A (en) Improvement in the fluoride stability in dicalcium phosphate dihydrate composition
PT81813B (en) Process for the preparation of acid 5,7-dihydro-6h-dibenzo<c,e>azepine-6-(thio)-carboxymidic esthers and pesticide compositions therewith
HUT44139A (en) Herbicide compositions containing quinoxalinyl-oxy-phenoxy-propionic acid derivatives as active components and process for producing the active components